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  Eubacterium coprostanoligenes has been found to be a cholesterol-reducing 
microorganism. To verify this, the bacteria were grown in Base Cholesterol Medium 
and its growth was studied by plating growing broth culture on agar solidified 
medium. It was found that cholesterol was not required for bacterial growth, and the 
growth was affected by lecithin, CaCl2 and pH of culture medium. In addition, being 
anaerobic, E. coprostanoligenes was found to survive when exposed to ambient air. 
Morphology of the bacterium was re-affirmed by confocal and transmission electron 
microscopy to be coccobacilloid.  
Cholesterol reduction activity in E. coprostanoligenes was studied using gas 
chromatography because of its practicality and accuracy. With this method, the 
conversion of cholesterol to coprostanol by E. coprostanoligenes was re-affirmed. 
The cholesterol reduction activity was found to be affected by lecithin, CaCl2 and pH 
of culture medium. In addition, the reaction could take place under aerobic condition. 
 Cholesterol reduction activity in E. coprostanoligenes was found to increase 
with increasing cholesterol concentration. A kinetics study of cholesterol reduction 
activity in these bacteria showed a Vmax of 14 µM cholesterol reduced/h and Km of 1 
mM cholesterol. The putative cholesterol reducing enzyme(s) appeared to be secreted 
constitutively and intracellularly. On the other hand, cholesterol reduction in E. 
coprostanoligenes was shown to take place via the indirect pathway. However, 
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 Hypercholesterolemia has been a major health problem particularly in 
developed countries. Being associated with coronary heart diseases (CHD), it can 
finally lead to death (Tell et al. 1994; Kromhout et al., 1995; Mann et al., 1997; 
Hegsted and Ausman, 1998). In Singapore, a quarter of the residents was found to 
have high total cholesterol levels (≥ 6.2 mmol/L) in the National Health Survey 
conducted in 1998 (Tan, 2000). Nevertheless, some reports have shown that the 
lowering of cholesterol levels could increase survival rate in CHD patients (Pederson, 
1994; Shepherd et al., 1995; Sacks et al., 1996). In view of this, various 
pharmacological agents (Hunninghake, 1990; März et al., 1997; Staels et al., 1998; 
Ros, 2000; Istvan, 2003) and dietary supplements (Crouse and Grundy 1979; Benitez 
et al., 1997; Howard and Kritchevsky, 1997; Danijela et al., 2003) have been 
developed with the chief aim of lowering plasma cholesterol levels. Statins have been 
established by far to be the most efficient cholesterol-lowering drug (Istvan, 2003). 
However, benefits aside, some of these agents (e.g. statins and fibrates) have been 
reported to incur side effects such as gastrointestinal disturbances and sleep disorders 
(Christian et al., 1998; Najib, 2002).  
 Cholesterol-reducing bacteria have the potential to serve as an alternative for 
cholesterol lowering (Dehal et al., 1991). These bacteria have the ability to convert 
cholesterol to coprostanol. Cholesterol-lowering ability is achieved as coprostanol is 
poorly absorbed in human intestines and would be excreted (Bhattacharyya, 1986). 
Cholesterol-reducing bacteria have been isolated from rat cecal contents (Eyssen et al., 
1973), faeces of human (Sadzikowski et al., 1977) and that of baboon (Brinkley et al., 
1982). These isolated cholesterol-reducing bacteria have been found to require 
plasmalogen for growth or for its cholesterol-reduction activity (Eyssen et al., 1973; 
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Sadzikowski et al., 1977; Brinkley et al., 1982). An exception however is 
Eubacterium coprostanoligenes, one of the isolated cholesterol-reducing bacteria, 
which has been established to not require plasmalogen for growth or cholesterol 
reduction activity (Freier et al., 1994). It was therefore a useful experimental 
microorganism to explore its cholesterol-lowering potential.   
 The aim of this project is to develop suitable methods to study factors 
affecting the growth and cholesterol reduction activity of E. coprostanoligenes. The 
information obtained from the study is prospected to be useful for future utilization of 




























2 LITERATURE REVIEW 
 
2.1 Cholesterol and health related issues 
Cholesterol homeostasis is maintained by balancing intestinal cholesterol 
absorption and endogenous cholesterol synthesis (Dietschy et al. 1993). Intestinal 
absorption of cholesterol shares complexity to that of triglycerides because both are 
water-insoluble molecules (Wilson and Rudel, 1994). Its absorption requires steps of 
emulsification, hydrolysis of ester bonds by specific pancreatic esterase, micellar 
solubilization, absorption in the proximal jejunum, re-esterification within the 
intestinal cells, and transport to the lymph in the chylomicrons (Wilson and Rudel, 
1994). Only 40 to 60 % of dietary cholesterol is absorbed independent of the amount 
ingested of up to 600 mg/day (Bosner et al., 1999) 
In addition to ingestion, cholesterol is synthesized and secreted from the liver 
as bile acids (Dietschy et al. 1993). A fraction of this biliary cholesterol is absorbed in 
the intestine due to the efficient re-absorption of bile acids. Dietary absorbed and 
endogenously synthesized cholesterol are transported as chylomicrons to liver where 
they are cleared efficiently for further processing (Dietschy et al., 1993). This process 
has been found to exert regulatory effects on whole-body cholesterol homeostasis 
(Dietschy et al., 1993). When the delivery of intestinal-absorbed cholesterol to the 
liver was increased, endogenous cholesterol synthesis is known to be inhibited in a 
proportional fashion with the increase in bile acids production. In this way, substantial 
variations of cholesterol intake induced minimal fluctuation in blood cholesterol level 
on human (Quintao et al., 1971). On the other hand, the response of blood cholesterol 
to changes in dietary cholesterol was found to vary between individuals (Lin and 
Cornor, 1980; Maranhao and Quintao, 1983). 
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Excess cholesterol from diet and bile acids are excreted in faeces (Dietschy et 
al. 1993). This cholesterol mass escaping intestinal absorption will be degraded to 
coprostanol through reduction of the double bond at C-5 by colonic bacteria before it 
is excreted (Macdonald et al., 1983). As such, it should be noted that the overall body 
cholesterol balance is kept mainly by matching cholesterol intake and synthesis with 
that of faecal loss. The latter is strictly dependent on intestinal cholesterol absorption 
which in turn is regulated by blood cholesterol levels (Dietschy et al. 1993). 
Cholesterol absorption appears to be a very specific process (Salen et al., 1970; 
Connor and Lin, 1981). Phytosterols like β-sitosterol, campesterol, and stigmasterol 
and marine sterols in shellfish have been found to be absorbed less efficiently (Salen 
et al., 1970; Connor and Lin, 1981). These sterols are structurally related to 
cholesterol differing only in the degree of saturation of the sterol nucleus or in the 
nature of the side chains at C-24. Absorption of β-sitosterol, which differed from 
cholesterol only by the addition of an ethyl group on C-24, was found to be less than 5 
% (Salen et al., 1970). 
Gender was found to be unrelated to the efficiency of cholesterol absorption 
(Bosner et al., 1999). On the other hand, cholesterol absorption has been proposed to 
be affected by genetics, physiology and dietary factors (Nestel et al., 1973; Vahouny 
et al., 1980; de Leon et al., 1982; Samuel et al., 1982; Watt and Simmonds, 1984; 
McMurry et al., 1985; Mahley, 1988; Thurnhofer et al., 1991; Ostlund et al., 1999). 
For example, studies have shown that polymorphism of apo E, a ubiquitous protein of 
lipid transport (Mahley, 1988) and mutation in the gene encoding for the putative 
intestinal cholesterol carrier protein (Thurnhofer et al., 1991) were genetic factors 
influencing cholesterol absorption. Physiologically, obesity was found to be 
negatively associated with absorption of cholesterol (Nestel et al., 1973). An increase 
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in the velocity of intestinal transit was associated with reduced cholesterol absorption 
and vice versa (de Leon et al., 1982). Detergent capacity of different types of bile 
acids in the enterohepatic circulation was also reported to influence cholesterol 
absorption (Watt and Simmonds, 1984). Increased fiber content in a meal would 
reduce cholesterol absorption due to physical interaction within the intestinal lumen 
(Vahouny et al., 1980) while the ingestion of cholesterol together with a significant 
amount of triglycerides in a diet facilitated cholesterol absorption (Samuel et al., 
1982).  
Hypercholesterolemia is a condition when the plasma cholesterol elevates 
above 6.2 mmol/L, as defined by the United States Department of Health and Human 
Services. A survey on cholesterol status among Singaporeans was conducted in 1998 
by the Epidemiology and Disease Control Department, Ministry of Health, Singapore. 
In a random sample of 4723 Singaporeans aged between 18 and 69 years, the survey 
found that a quarter (25.4 %) of them had high total cholesterol levels (≥ 6.2 mmol/L), 
35.3 % with borderline-high levels (5.2-6.2 mmol/L) and 39.3 % at desirable levels (< 
5.2 mmol/L) (Tan, 2000). The survey also showed that 94.8 % of Singapore residents 
had desirable HDL (High Density Lipoprotein)-cholesterol levels (≥ 0.9 mmol/L). On 
the other hand, 26.5 % of Singapore residents had high LDL (Low Density 
Lipoprotein)-cholesterol levels (≥ 4.1 mmol/L) and 30.2 % had borderline-high levels 
(3.3-4.1 mmol/L) (Tan, 2000). More males (27.3 %) than females (23.5 %) had high 
total cholesterol level. Overall, there was a significant increase in the age-
standardized prevalence of high blood cholesterol from 1992 to 1998 (19.4 % and 
25.4 %, respectively), mean total cholesterol (1992, 5.3 mmol/L; 1998, 5.5 mmol/L) 
and crude prevalence of high LDL-cholesterol (1992, 22.9 %; 1998, 26.5 %). There 
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was no significant difference in the overall age-standardized prevalence low HDL-
cholesterol (1992, 6.0 %; 1998, 5.2 %) (Tan, 2000). 
CHD have always been related to hypercholesterolemia (McNamara, 2000). 
Using simple regression analyses, dietary cholesterol has been found to be positively 
correlated to both plasma total cholesterol level and CHD incidence in many 
epidemiological studies (Hegsted and Ausman, 1988; Tell et al. 1994; Kromhout et 
al., 1995; Mann et al., 1997). 
Hegsted and Ausman (1988) reported that dietary cholesterol was significantly 
related to CHD incidence. Tell et al. (1994) revealed that elevated cholesterol level 
resulted in a thickened carotid artery wall, which gives rise to CHD. Kromhout et al. 
(1995) measured risk factors for CHD and suggested that dietary cholesterol was an 
important determinant of the differences in the population rates of CHD death. 
However, the authors also suggested that cholesterol intake could be a surrogate 
marker for two other factors which also contributed to increased CHD risk: a) a high 
intake of saturated fat resulting in elevated plasma cholesterol levels; and b) a dietary 
pattern low in fruits, grains and vegetables hence resulting in low intakes of B vitamin, 
antioxidants and dietary fiber. Mann et al. (1997) reported that the deleterious effect 
of dietary cholesterol appeared to be more important in cases of CHD than the 
protective effect of dietary fiber. In contrast, Esrey et al. (1996) and Ascherio et al., 
(1996) concluded that dietary fat and cholesterol intake were not significantly 
associated with CHD mortality. Lipid-heart hypothesis which proposes that elevated 
fat and cholesterol intake increase the risk of developing CHD might be overly 
simplistic. 
The evidence to establish the relationship between dietary cholesterol and 
CHD incidence has been complicated by the co-linearity of saturated fat with 
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cholesterol in the diet (Hegsted and Ausman, 1988; Kromhout et al., 1995; Mann et 
al., 1997). Eggs are high –cholesterol low-saturated fat food. Studies on egg 
consumption indicated that dietary cholesterol was not associated with risk of CHD 
(Dawber et al., 1982; Hu et al., 1999). The apparent association between total dietary 
cholesterol and CHD mortality rates was hence explained by the association between 
dietary saturated fat calories and dietary cholesterol, and the low fiber intakes in diets 
high in animal products (Ascherio et al., 1996; Hu et al., 1997; Hu et al., 1999).  
 Artaud-Wild et al. (1993) reported that different populations consuming diets 
with similar amount of cholesterol and saturated fat could incur different CHD 
incidence rates. It was shown that maintaining a high intake of cholesterol and 
saturated fat in the diet, people who consumed more plant foods, including small 
amount of vegetable oils, and more vegetable (more antioxidants) had lower rates of 
CHD mortality. Similarly, it has also been shown that patients who died from CHD 
had a lower vegetable food intake and a higher animal food intake than controls 
(Kushi et al., 1985).  
Even though plasma cholesterol response to dietary cholesterol is highly 
variable between individuals, the general consensus, as obtained from clinical trials of 
the effect of dietary cholesterol on plasma cholesterol, is that dietary cholesterol 
intake does exert a statistically significant, small effect on plasma cholesterol levels 
(Glatz et al., 1993).  
The quantitative importance of dietary fatty acids and cholesterol to blood 
concentrations of total, LDL-, and HDL-cholesterol was determined by Clarke et al., 
(1997). The study showed that total blood cholesterol was reduced by about 0.8 
mmol/L, with four fifths of this reduction being in LDL-cholesterol, when 60 % of 
saturated fats were replaced by unsaturated fats in a diet and cutting down 60 % of 
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dietary cholesterol. However, it should be hereby emphasized that the effects of 
dietary cholesterol on plasma total cholesterol cannot provide a true estimation of its 
effects on CHD risk since changes can occur in both the atherogenic LDL-cholesterol 
as well as in the anti-atherogenic HDL fraction. Numerous cholesterol feeding studies 
are supporting this notion since they suggest that LDL: HDL cholesterol ratio is 
unaltered by dietary cholesterol (Ginsberg et al., 1994; Ginsberg et al., 1995; Knopp 
et al., 1997).   
 Even though the relationship between dietary cholesterol and incidence of 
CHD remained elusive, many studies have shown that lowering the cholesterol level 
could increase survival rate in CHD patients (Pedersen, 1994; Shepherd et al., 1995; 
Sacks et al., 1996). Pedersen (1994) showed that lowering cholesterol level using 
simvastatin improved survival in CHD patients by 30 %. This finding was replicated 
when hypercholesterolemia patients with no history of myocardial infarction were 
administrated with pravastatin: a reduction in total mortality of 22 % and a reduction 
in CHD (fatal and non-fatal) of 31 % (Shepherd et al., 1995). The benefit of 
cholesterol-lowering therapy with pravastatin was also demonstrated in patients with 
CHD where 24 % reduction in CHD mortality was observed (Sacks et al., 1996).  
It was estimated that a long-term reduction in serum cholesterol concentration 
of 0.6 mmol/L (10 %) could lower the risk of heart disease by 50 % at age of 40, 
which could then fall to 20 % at age 70 (Law et al., 1994). In view of this, various 
pharmacological agents (Hunninghake, 1990; März et al., 1997; Staels et al., 1998; 
Ros, 2000; Istvan, 2003) and dietary supplements (Crouse and Grundy 1979; Benitez 
et al., 1997; Howard and Kritchevsky, 1997; Danijela et al., 2003) have been 
developed with the chief aim to lower plasma cholesterol level. 
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2.2 Pharmacological agents in cholesterol lowering 
Pharmacological agents commonly employed in the treatment of 
hypercholesterolemia include: 1) 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-
CoA) reductase inhibitors (or statins) (Istvan, 2003); 2) bile acid sequestrants 
(Packard and Shepherd, 1982; Ast and Frishman, 1990); 3) fibrates (Staels et al., 
1998); 4) ursodeoxycholic acid (Ros, 2000) and neomycin (Sedaghat et al., 1975); 
and 5) lifibrol (März et al., 1997). 
 The effectiveness of statins is related to the action of HMG-CoA reductase 
which converts HMG-CoA to mevalonate. This is a control step in the biosynthesis of 
cholesterol and inhibition of this enzyme will result in a decreased synthesis of 
cholesterol and other products downstream of mevalonate (Istvan, 2003). Statins are 
competitive inhibitors of HMG-CoA reductase (Istvan, 2003). They have been 
therapeutically used to reduce risk of CHD by reducing cholesterol synthesis and 
upregulating LDL receptors in the liver, consequently giving rise to a decreased level 
of circulating cholesterol (Istvan, 2003). Other anti-atherogenic effects of statins 
include: a) reduction of plasma viscosity and decreased platelet aggregation, b) 
production of a relaxing effect on smooth muscle that could potentially result in a 
reduction in blood pressure, and c) partially reverse vascular hyper-reactivity 
associated with hypercholesterolemia (Christian et al., 1998). The most important side 
effects associated with the use of statins are hepatotoxicity and myopathy. Other 
common adverse events include gastrointestinal disturbances, dyspepsia, myalgia, 
headache, sleep disorders and central-nervous-system disturbances (Christian et al., 
1998) 
 Not only is the hepatic synthesis of bile acids from cholesterol a major 
component of cholesterol homeostasis, it is also a major route of cholesterol excretion. 
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Bile acids sequestrants basically engaged in hepatic bile acid synthesis and excretion 
to reduce concentrations of plasma cholesterol (Packard and Shepherd, 1982; Ast and 
Frishman, 1990). Cholestyramine, a bile acids sequestrant, has been widely prescribed 
for the treatment of hypercholesterolemia (Hunninghake, 1990) and was reported to 
cause a 38 % decrease in cholesterol absorption (McNamara et al., 1980). 
Fibrates are useful in the treatment of hypercholesterolemia in that it can result 
in a substantial decrease in plasma triglycerides. It has been found to be able to 
decrease LDL cholesterol levels while increasing HDL cholesterol concentrations 
(Staels et al., 1998). Adverse effects of fibrates administration include gastrointestinal 
symptoms, cholelithiasis, hepatitis, myositis, and rash (Najib, 2002). The combination 
of fibrate and statin was found to provide complementary cholesterol lowering effects 
(Farnier et al., 2003). 
The fourth pharmacological agent commonly employed is ursodeoxycholic 
acid, which has the lowest micellar cholesterol-solubilizing ability of all common bile 
acids (Armstrong and Carey, 1982). Enrichment of endogenous bile acid pool with 
ursodeoxycholic acid was found to reduce both biliary cholesterol secretion and 
intestinal absorption as a result of inefficient cholesterol absorption (Fromm, 1984). 
Neomycin is a non-absorbable aminoglycoside antibiotic with cholesterol-lowering 
effect by interfering with the micellar solubilization of cholesterol in the digestive 
tract (Sedaghat et al., 1975).  
Last but not least, lifibrol {4-(4’-tert-butylphenyl)-1-(4’-carboxyphenoxy)-2-
butanol} has been found to reduce cholesterol absorption from the intestine. It was 
also shown to moderately decrease hepatic cholesterol biosynthesis and stimulate the 
expression of LDL receptors (März et al., 1997).  
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2.3 Dietary supplements in cholesterol lowering 
Dietary supplements with cholesterol-lowering property include: 1) plant 
sterols (Howard and Kritchevsky, 1997); 2) soy lecithin (Boststo et al., 1981; Wilson 
et al., 1998); 3) sucrose polyester (olestra) (Prince and Welschenbach, 1998); and 4) 
policosanol (Benitez et al., 1997; Canetti et al., 1997). 
Plant sterols (phytosterols), despite being synthesized in plants, are 
structurally similar to cholesterol. They are however minimally absorbed from the gut 
(Salen et al., 1970). Ingestion of free phytosterols, especially β-sitosterol, has been 
shown to reduce plasma cholesterol in both animals and humans (Howard and 
Kritchevsky, 1997). Saturated plant sterol derivatives (termed plant stanols) are 
produced by the hydrogenation of sterols (Howard and Kritchevsky, 1997). Addition 
of plant sterol or stanol to margarine spread reduced serum concentrations of LDL-
cholesterol and the risk of heart disease (Low, 2000; Neil and Huxley, 2002). The 
esterified forms of phytosterols have higher lipid solubility and could be used as 
cholesterol-lowering agents (Howard and Kritchevsky, 1997). The putative 
mechanisms by which plant sterols and stanols reduced serum cholesterol were found 
to include (a) inhibition of cholesterol absorption in the gastrointestinal tract by 
displacing cholesterol from micelles, (b) limiting the intestinal solubility of 
cholesterol, and (c) decreasing the hydrolysis of cholesterol esters in the small 
intestine (Ling and Jones, 1995). 
 Plasma cholesterol levels were also found to be significantly reduced when 
rats were fed with soy protein (Boststo et al., 1981). The cholesterol-lowering 
efficacy of a diet could be enhanced with the addition of soy lecithin (Wilson et al., 
1998). It has been found that the inclusion of soybean Leci-Vita, a product rich in 
polyunsaturated phospholipids (with 7 % lecithin, 17 % soy protein), to a diet 
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significantly reduced total and LDL-cholesterol in patients with elevated serum 
cholesterol while causing HDL-cholesterol to significantly increase (Danijela et al., 
2003). Jimenez et al. (1990) reported that the plasma lecithin-cholesterol-
acyltransferase (LCAT) activity increased when lecithin was administrated to 
hypercholesterolemic rats. Enhanced LCAT activity in turn increased the formation of 
mature HDL and cholesterol removal.  
 Olestra is prepared from sucrose and long-chain fatty acids from edible fats 
and oils such as soybeans, corns and cottonseeds (Prince and Welschenbach, 1998). It 
has the physical properties of fat but is unabsorbable and hence used exclusively as fat 
substitute in some commercial snacks (Prince and Welschenbach, 1998). A significant 
reduction in cholesterol absorption was observed when feeding olestra to human 
(Crouse and Grundy 1979). No toxicity of olestra was shown when fed to dogs 
(Miller et al., 1991). 
 Policosanol comprised of 8 higher aliphatic alcohols obtained from sugar cane 
(Saccharum officinarum) (Canetti et al., 1997). Studies have established the 
cholesterol lowering effect of policosanol in patients with hypercholesterolemia 
(Benitez et al., 1997; Canetti et al., 1997). No toxicity was observed even at high 
dosage of policosanol (Mesa et al., 1994).  
 
2.4 Sterol reductases 
 Sterol reductases, the enzymes that catalyze the reduction of C=C double bond 
of sterols have been widely studied (Bottema and Park, 1978; Wiłkomirski and Goad, 
1983; Dehal et al., 1991; Taton and Rahier, 1991; Kim et al., 1995; Smith, 1995; 
Holmer et al., 1998; Silve et al., 1998; Bae et al., 1999; Schrick et al., 2000). Among 
these, the enzyme catalyzing the reduction reaction of cholesterol was designated as 
 13
“cholesterol reductase” irrespective of the reaction mechanism and the biological 
source (Dehal et al., 1991). This enzyme was reported to convert cholesterol to 
coprostanol (Dehal et al., 1991). Though coprostanol is structurally similar to 
cholesterol, the former was found to be poorly absorbed by intestine (Bhattacharyya, 
1986). Cholesterol reductase is therefore an efficient way to lower cholesterol 
concentration. 
 Other than cholesterol reductase, 7-dehydrocholesterol reductase that catalyzes 
the reduction of C-7 double bond of 7-dehydrocholesterol to cholesterol was 
identified in microsomes of Zea mays (Taton and Rahier, 1991). Two genes, assigned 
as TM7SF2 and DHCR7, with strong sequence similarity to carboxyl-terminal 
domain of human lamin B receptor and 7-dehydrocholesterol reductase were 
described (Holmer et al., 1998). They were reported as human gene family encoding 
proteins that functioned in nuclear organization and/or sterol metabolism. The cDNA 
encoding rat 7-dehydrocholesterol reductase had since been cloned and sequenced 
(Bae et al., 1999). It appears to share a closed amino acid identity with mouse and 
human 7-dehydrocholesterol reductase and highly hydrophobic. Mutations in the 7-
dehydrocholesterol reductase gene have been known to give rise to Smith-Lemli-
Opitz Syndrome characterized by facial dysmorphisms, mental retardation and 
multiple congenital anomalies (Wassif et al., 1998; Waterham et al., 1998). 
C14-sterol reductase catalyzes the reduction of C8=C14 or C7=C14 double 
bond of sterols (Kim et al., 1995). It was identified in Saccharomyces cerevisiae 
(Bottema and Parks, 1978). Following that, it has been purified from rat microsomes 
and was found to be induced by cholesterol (Kim et al., 1995). Schizosaccharomyces 
pombe erg24 cDNA which encodes a C14-sterol reductase has been cloned and 
sequenced (Smith, 1995). It was found to bear significant homology with that of 
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Saccharomyces cerevisiae. Human lamin B receptor was suggested as a C14-sterol 
reductase because it restored the C14 reduction step when transformed in mutated 
Saccharomyces cerevisiae lacking C14-sterol reductase (Silve et al., 1998). FACKEL, 
a gene that required for organized cell division and expansion in Arabidopsis 
embryogenesis was found to encode a C14-sterol reductase (Schrick et al., 2000). The 
C14-sterol reductase activity was found to be inhibited by 15-azasterol (Bottema and 
Park, 1978), 7-aminocholesterol (Elkihel et al., 1994), fenpropimorph and tridemorph 
(Silve et al., 1998). 
 C25-sterol reductase, an enzyme that catalyzes the conversion of (24S)-24-
ethylcholesta-5,22,25-trien-3β-ol to (24S)-24-ethylcholesta-5,22-dien-3β-ol was 
identified in alga Trebouxia sp. (Wiłkomirski and Goad, 1983). Mutation in the C24-
sterol reductase gene was found to cause desmosterolosis, which is characterized by 
multiple congenital anomalies (Waterham et al., 2001). 23-Azacholesterol was found 
to inhibit C24-sterol reductase in Saccharomyces cerevisiae (Pierce Jr. et al., 1978). 
Genetic defects of sterol metabolism in humans and mice that involved impairment of 
sterol reductases has been discussed (Moebius et al., 1998). 
 
2.5 Cholesterol reductase in plants  
 Cholesterol functions in plants as hormone and hormone precursors, 
architectural components of membrane and have also been postulated to play a role in 
seed germination and plant growth (Grunwald, 1975). Generally speaking, the amount 
of cholesterol present in a given plant source is of no indication to its relative 
importance because the turnover rate of cholesterol is very high (Hefmann, 1984). 
 Examination of the structures of the various steroids formed from cholesterol 
by plants indicated that cholesterol must have undergone a series of oxidation and 
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reduction reactions in the process (Hefmann, 1984). The oxidation of cholesterol to 4-
cholesten-3-one was demonstrated in vitro with Solanum tuberosum and Cheiranthus 
cheiri leaves as well as with suspension cultures of Brassica napus and Glycine max 
(Hefmann, 1984). 4-Cholesten-3-one has been found to undergo reduction to 5α-
cholestan-3β-one in the presence of Strophanthus kombé, and Cheiranthus cheiri leaf 
homogenates. It is converted to 5α-cholestan-3β-ol in the suspension cultures of rape 
and soya cell (Hefmann, 1984). 5α-Cholestan-3β-ol (isomer of coprostanol) was 
found to be absorbed only half as efficiently as cholesterol by intestine 
(Bhattacharyya, 1986). 
 Various steroid transformations have been found to occur in plants (Hefmann 
et al., 1967; Lin et al., 1983). For example, in Lycopersicon pimpinellifolium, the 
C5=C6 double bond of cholesterol is reduced to form tomatidine (Hefmann et al., 
1967). Lin et al. (1983) observed that androst-4-en-3,17-dione was metabolized into a 
variety of steroids in cucumber plants (Cucumis sativum). Dehal et al. (1988, 1990a, 
1990b) studied the conversion of cholesterol to coprostanol in plants. The homogenate 
from young cucumber leaves was found to catalyze the reduction of 7 % of 
cholesterol to coprostanol (Dehal et al., 1988). Last but not least, partial purification 
of cholesterol reductase from alfalfa (Medicago sativa) leaves and identification of 
cholesterol reductase activity in pea (Pisum sativum) were also reported (Dehal et al., 
1990a, 1990b; Yang and Beitz, 1992).  
 
2.6 Cholesterol reductase in bacteria 
 In view of the fact that coprostanol is found in faeces, many attempts have 
been made to isolate bacteria capable of reducing cholesterol to coprostanol from 
human and animal faeces (Snog-kjaer et al., 1956; Crowther et al., 1973). Certain 
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anaerobic bacteria from human faeces are known to hydrogenate cholesterol in vitro 
(Snog-kjaer et al., 1956). On the other hand, microbial degradation of cholesterol and 
plant sterols have been found to occur in Mycobacterium sp. NRRL B-3683 and 
Mycobacterium sp. NRRL B-3805 producing androsta-1,4-diene-3,17-dione and 
androst-4-ene-3,17-dione (Marsheck et al., 1972). Cholesterol reduction by common 
intestinal bacteria such as Bifidobacterium, Clostridium, and Bacteriodes has also 
been reported (Crowther et al., 1973). Goddard and Hill (1974) found that bacterial 
flora in the guinea pig gut can degrade cholesterol. The in vivo reaction was abolished 
by pretreatment of the animals with antibiotics which suppressed the gut bacterial 
flora. On the other hand, degradation of cholesterol from liquid media was reported in 
fast-growing non-pathogenic mycobacteria (Av-Gay and Sobouti, 2000). 
 Wiggers et al. (1973) showed that despite the high cholesterol level (250 
mg/kg body weight daily) fed to calves, their plasma cholesterol was not higher than 
in grain-fed calves which had received no cholesterol in their diet. It was thus 
postulated that the cholesterol ingested had undergone microbial degradation in the 
ruminoreticulum. The postulation was confirmed by Ashes et al. (1978) who showed 
that cholesterol was hydrogenated by anaerobic incubation with sheep rumen fluid. 
The principal product of cholesterol hydrogenation was later identified to be 
coprostanol. 
 Microorganisms that have the ability to hydrogenate cholesterol to coprostanol 
have been isolated from rat cecal contents (Eyssen et al., 1973), the faeces of human 
(Sadzikowski et al., 1977) and that of baboon (Brinkley et al., 1982). The cholesterol-
reducing microorganism isolated from rat cecal contents, Eubacterium ATCC 21408, 
is an obligate anaerobe, measuring 0.3 to 0.5 µm by 1 µm in size, and is gram positive 
in very young culture. This strain is different from the previously described 
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Eubacterium in its requirement of cholesterol for growth (Eyssen et al., 1973). The 
bacteria are able to reduce C5=C6 double bond of cholesterol, campesterol, β-
sitosterol and stigmasterol to yield the corresponding 5β-saturated derivatives. No 
reduction reaction has been known to occur when 3-hydroxyl functional group was 
absent or altered (Eyssen et al., 1973). 
 An anaerobic, gram-positive diplobacillus that reduced cholesterol to 
coprostanol was also isolated from human faeces (Sadzikowski et al., 1977) and it 
was found to display similar characteristics to the cholesterol-reducing bacterium 
isolated from rat cecal contents by Eyssen et al. (1973). These anaerobes would not 
form colonies and were isolated and cultivated in an anaerobic medium containing 
homogenized pork brain (naturally high in cholesterol). They also required free or 
esterified cholesterol and alkenyl ether lipid (plasmalogen) for growth (Sadzikowski 
et al., 1977). 
 Nine strains of cholesterol-reducing bacteria have been isolated and 
characterized from faeces and intestinal contents of baboons (Brinkley et al., 1982). 
Unlike previously reported strains, these nine strains did not require cholesterol and 
plasmalogen for growth (Brinkley et al., 1982). However, only two strains reduced 
cholesterol in the absence of plasmalogen. These two strains also produce succinate as 
end product (Brinkley et al., 1982). 
 The role of cholesterol in growth of these organisms has not been reported. 
Eyssen et al. (1973) suggested that cholesterol could be the terminal electron receptor. 
However, all strains isolated from faeces and intestinal contents of baboons had not 
required cholesterol for growth (Brinkley et al., 1982). Therefore, an alternative 
electron would have to be used by these strains when cholesterol was not available 
(Brinkley et al., 1982). That aside, it has been reported that Eubacterium ATCC 
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21408 is able to grow well in standard brain medium (Eyssen et al., 1973). However, 
colonies of the bacteria did not develop on the media solidified with agar (Brinkley et 
al., 1980). Colonies of the bacteria were found to develop when cholesterol 
concentration was increased to 5 % (Brinkley et al., 1982) which suggested the 
importance of cholesterol in bacterial growth.  
The usual end product of microbial cholesterol reduction in soil and sediments 
was found to be 5α-cholestan-3β-ol while that in the intestine was coprostanol (5β-
cholestan-3β-ol) (Gaskell and Eglinton, 1975). Coprostanol, cholesterol, stigmasterol 
and β-sitosterol have been detected in natural water and sediments (Hassett and Lee, 
1977). Coprostanol, a ubiquitous organic residue in the soil, has been selected to be a 
biomarker of a variety of human activities such as settlement organization and 
manuring practices in archaeological study as it provides an indication of prior human 
settlement (Bethell et al., 1994). On the other hand, the faecal stanol/sterol ratio has 
been established to be a suitable parameter for the comparison of sewage 
contamination in sediments (Chan et al., 1998). The amount of coprostanol in urine 
collection tank can also be used as an indicator of faecal cross-contamination (Sundin 
et al., 1999). 
 The mechanism of cholesterol reduction to coprostanol has been studied 
(Schoenheimer, 1935; Rosenfeld et al., 1956; Björkhem and Gustafsson, 1971). 
According to Schoenheimer (1935), bacterial conversion of cholesterol to coprostanol 
involved the initial oxidation of cholesterol to 4-cholesten-3-one, followed by the 
successive reduction to coprostanone and finally to coprostanol. In contrast, 
Rosenfeld et al. (1956) eliminated the ketones from the pathway for coprostanol 
formation. This direct stereospecific reduction of the C5=C6 double bond was later 
invalidated by Björkhem and Gustafsson (1971) who demonstrated that conversion of 
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cholesterol into coprostanol by cecal contents of rat proceeded to at least 50 % by 
means of the formation of the intermediate 4-cholesten-3-one. 
 
2.7 Eubacterium coprostanoligenes  
 The cholesterol-reducing bacteria discussed in this literature review thus far 
require plasmalogen for growth or cholesterol-reduction activity (Eyssen et al., 1973; 
Sadzikowski et al., 1977; Brinkley et al., 1982). Plasmalogen was provided to the 
bacteria by the inclusion of brain extract in the growth medium (Mott and Brinkley, 
1979) which consequently made the culture medium viscous. This in turn made the 
separation of the bacteria from growth medium very difficult.  
 Freier et al. (1994) reported a new bacteria species, Eubacterium 
coprostanoligenes, which was isolated from hog sewage lagoon in Iowa, U.S.A. The 
coccobacilloid cells are small and occurred singly or in pair. They are nonmotile, 
gram positive and non-spore forming. Optimal growth and coprostanol production 
were reported to be at pH 7.0 and at 35 °C (Freier et al., 1994). These bacteria could 
metabolize lecithin, a substrate necessary for growth. Cholesterol was found to be 
reduced to coprostanol by the bacteria, but was not required for growth (Freier et al., 
1994). Unlike previously described cholesterol-reducing bacteria, plasmalogen was 
neither required for growth nor for cholesterol-reduction activity in this case. In 
addition, while the bacteria required anaerobic conditions to grow, they could survive 
long exposure to atmospheric oxygen for up to 48 hours (Freier et al., 1994). Li et al. 
(1995b) considered E. coprostanoligenes to be more amenable than previously 
studied cholesterol-reducing bacteria for application in the food and pharmaceutical 
industries. 
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 E. coprostanoligenes possesses phospholipase activity. It was suggested that 
the metabolites of phospholipase activity alter the bacterial membrane, thus increasing 
the accessibility of the cholesterol to cholesterol reductase (Freier et al., 1994). It was 
also suggested that calcium chloride in the growth medium provided the net positive 
charge required for phospholipase activity. The subsequent hydrolysis of 
phosphatidylcholine by phospholipase is either a cofactor or is directly involved in 
coprostanol formation (Freier et al., 1994). A resting-cell assay was established to 
evaluate the cholesterol reductase activity of E. coprostanoligenes (Li et al., 1995b). 
 The reduction mechanism of cholesterol to coprostanol by E. 
coprostanoligenes was studied by incubating the bacterium with a mixture of α- and 
β-isomers of [4-3H, 4-14C] cholesterol (Ren et al., 1996). The results suggested that 
the major pathway for cholesterol reduction in E. coprostanoligenes involved the 
intermediate formation of 4-cholesten-3-one and coprostan-3-one followed by the 
reduction of latter to coprostanol.  
 The hypocholesterolemic effect of E. coprostanoligenes has been studied in 
rabbits (Li et al., 1995a), laying hens (Li et al., 1996a) and germ-free mice (Li. et al., 
1998). Oral administration of the bacteria caused a significant hypocholesterolemic 
effect in rabbits (Li et. al, 1995a). The effect was explained by the conversion of 
cholesterol to coprostanol in the intestine. In laying hens, plasma cholesterol 
concentrations were not affected by the bacterial treatment despite an increase in the 
coprostanol-to-cholesterol ratio in faeces (Li et al., 1996a). The hypocholesterolemic 
effect of E. coprostanoligenes was found to be transient in germ-free mice as the 






GROWTH OF EUBACTERIUM COPROSTANOLIGENES 
 
3.1 Introduction 
 E. coprostanoligenes was isolated by Freier et al. (1994). It was reported as a 
small, anaeorobic and gram-positive coccobacillus that was able to convert 
cholesterol to coprostanol. It showed optimal growth at pH 7 and at temperature of 35 
°C. Growth was not evident at pH 5.5 or 8 and at temperatures of 25 or 45 °C (Freier 
et al., 1994). Other than E. coprostanoligenes, cholesterol-reducing bacteria have also 
been isolated from rat cecal contents (Eyssen et al., 1973), faeces of human 
(Sadzikowski et al., 1977) and baboon (Brinkley et al., 1982). The requirement of a 
strict anaerobic condition posed an obstacle to the investigation of growth of these 
organisms (Eyssen et al., 1973; Sadzikowski et al., 1977; Brinkley et al., 1982). E. 
coprostanoligenes should be more easily studied since it was reported to survive 
exposure to air for up to 48 hours and not required plasmalogen for growth (Freier et 
al., 1994). 
 The objectives of this chapter are to study the growth of E. coprostanoligenes 
as well as various factors affecting its growth. The study would provide useful 
information on the growth behavior of these special bacteria and how its growth could 
be enhanced. 
 
3.2 Materials and Methods 
3.2.1 E. coprostanoligenes and Base Cholesterol Medium (BCM) 
 E. coprostanoligenes was purchased from American Type Culture Collection 
(ATCC Number: 51222, isolated from hog waste lagoon, Iowa). BCM was prepared 
by mixing cholesterol (2 g) and lecithin (1 g) with stirring in 200 ml of milli-Q water 
under nitrogen gas for 10 min, and subsequently combined with 800 ml of milli-Q 
 22
water dissolved with casitone (10 g), yeast extract (10 g), sodium thioglycollate (0.5 
g), CaCl2 (1 g) and resazurin (1 mg). The medium was adjusted to pH 7.5 with 5 M 
KOH and boiled under N2 until resazurin turned colorless before autoclaving at 121 
°C for 20 min. BCM was mixed well after autoclaving and placed in anaerobic 
chamber (Sheldon Manufacturing Inc., U.S.A.) before being inoculated with the 
bacteria. Cholesterol-free BCM was prepared with the same procedure without adding 
cholesterol. Bacterial cultures were maintained by weekly transfers of 20 ml bacterial 
culture to 200 ml fresh BCM.  
 
3.2.2  Plating of bacteria on agar solidified medium 
Agar solidified medium was prepared as BCM with the addition of 1.5 % (w/v) 
agar before autoclaving. About 25 ml medium was dispensed into each 90 mm 
diameter Petri dish.  Solidified medium were placed in anaerobic chamber for 2 hours 
to ensure a fully reduced (deoxygenation) state of medium. Bacterial culture (100 µl) 
was spread evenly on agar solidified medium with glass beads, and sealed with 
parafilm to avoid dehydration. The bacterial culture could be diluted to avoid 
overcrowding of colonies on surface of solidified medium. Inoculated plates were 
inverted and incubated overnight under anaerobic conditions at 37 °C. Colonies 
formed on surface of solidified medium were counted with naked eyes.  
To investigate the suitability of plate counting as a method to study growth of 
E. coprostanoligenes, bacterial culture was diluted at 103 to 108 times and inoculated 
on agar solidified medium in triplicate. To study the effect of cholesterol on growth of 
E. coprostanoligenes, agar solidified medium were prepared and inoculated with 
growing broth culture from BCM and cholesterol-free BCM. Inoculation and counting 
of colonies were conducted daily in triplicate until the growth of bacteria reached 
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death phase (as reflected by a decrease in the number of colonies on agar solidified 
medium).  
 
3.2.3 Microscopy study  
3.2.3.1 Confocal microscopy 
 Fresh culture was grown in liquid medium, pelleted by centrifuging at 10,000 
g, washed twice with 1 % (w/v) NaCl and suspended in the same solution. A drop of 
the suspended culture was transferred onto a slide with an inoculation loop and 
covered with a cover-slip. Images of E. coprostanoligenes observed in the 
transmission mode after excitation at 543 nm were captured with Zeiss LSM 510.  
 
3.2.3.2 Gram staining  
 Fresh culture was grown in liquid medium, pelleted by centrifuging at 10,000 
g, washed twice with 1 % (w/v) NaCl and suspended in the same solution. A drop of 
the suspended culture was transferred onto a slide with an inoculation loop and 
smeared into a very thin layer using a wooden stick. The culture was then air dried. A 
drop of crystal violet stain (2 g of crystal violet was dissolved in 20 ml of 95 % 
ethanol as solution A; 0.8 g of ammonium oxalate was dissolved in 80 ml of milli-Q 
water as solution B; solutions A and B were mixed and stored for 24 hours before use) 
was added over the dried culture for 10 seconds. Excess stain was then poured off. 
The culture was then further rinsed gently with a stream of water from a plastic water 
bottle.  
Iodine solution (1 g of iodine crystal and 2 g of KI were dissolved in 300 ml of 
milli-Q water) was added just enough to cover the culture and allowed to stand for 10 
seconds. After that, the iodine solution was poured off and the slide was rinsed with 
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water. A few drops of decolorizer (acetone/ethanol, 50:50 v/v) were added and 
allowed to trickle down the slide. The decolorizer was rinsed off with water after 5 
seconds. Rinsing was continued until the decolorizer was no longer colored as it 
flowed over the slide. The smear was counterstained with saffranin solution (2.5 g of 
saffranin O was dissolved in 100 ml of 95 % ethanol as stock solution; 10 ml of stock 
solution was diluted with 90 ml of milli-Q water as working solution) for 60 seconds. 
The saffranin solution was washed off with water and the slide was blotted dry. The 
specimen was examined under Olympus BH-2 light microscope. Images of stained 
cells were captured with Olympus CAMEDIA C-5050 Zoom digital camera. 
 
3.2.3.3 Transmission electron microscopy  
 Fresh culture was grown in liquid medium, pelleted by centrifuging at 10,000 
g, washed twice with 1 % (w/v) NaCl and suspended in the same solution. A drop of 
suspended culture was placed onto the Formvar-coated copper grid. One drop of 2 % 
(v/v) phospho-tungstate acid was added onto the copper grid and allowed to stand for 
1 minute. Excess stain was blotted dry and the copper grid was dried under table lamp 
for 3 min. The specimen was examined under Philips CM10 electron microscope.  
 
3.2.4 Factors affecting growth of bacteria 
BCM containing 1 mM cholesterol with a) lecithin concentrations varying 
from 0 to 10 g/l; b) CaCl2 (calcium chloride) concentrations varying from 0 to 10 g/l; 
and c) pH adjusted to 4, 5, 6, 6.5, 7, 7.5, 8, 9 and 10, were prepared and autoclaved, 
respectively. The media were then reduced in anaerobic chamber for 2 hours. Ten ml 
each of these media was inoculated with 1 ml of 24-hour-old culture (containing 
approximately 106 cells) and incubated at 37 °C in anaerobic chamber. Plate counting 
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was performed after 24 hours of incubation to study the growth of bacteria at different 
lecithin and CaCl2 concentrations and pH. Each test was carried out in triplicate.  
 
3.2.5 Aerotolerance of E. coprostanoligenes 
BCM containing 1 mM cholesterol with sodium thioglycollate concentrations 
varying from 0 to 5 g/l were prepared and autoclaved. The media were then reduced 
in anaerobic chamber for 2 hours. Ten ml of media containing different sodium 
thioglycollate concentrations was inoculated with 1 ml of 24-hour-old culture 
(containing approximately 106 cells) and incubated at 37 °C in anaerobic chamber. 
Plate counting was performed after 24 hours. Each test was carried out in triplicate  
 BCM with (0.5 g/l) and without sodium thioglycollate were prepared and 
autoclaved. Ten ml of each media was inoculated with 1 ml of 24-hour-old culture 
(containing approximately 106 cells) and incubated in anaerobic chamber at 37 °C. On 
the other hand, 10 ml of each media was exposed to ambient air (aerobic condition) 
by shaking in a shaker incubator for two hours. They were then inoculated with the 
same bacterial culture and incubated in the same shaker incubator at 37 °C. Plate 
counting was carried out every 12 hours for 60 hours. Each test was carried out in 
triplicate. 
 
3.2.6 Statistical analysis 
Where necessary, statistical tests were conducted using one-way ANOVA 
(Tukey’s Test) to determine if the treatments in each experiment were significantly 
different from one another at 95 % confidence level. 
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3.3 Results and Discussion 
3.3.1 Culture medium for E. coprostanoligenes  
E. coprostanoligenes was cultured in BCM which is a cloudy lipid suspension. 
Lecithin in BCM is required for growth of E. coprostanoligenes (Freier et al., 1994). 
Boiling the medium before autoclaving is an important step in the preparation of 
BCM as cholesterol and lecithin are not readily dissolved in the mixture. Boiling will 
enable a finer lipid suspension to be formed which might facilitate bacterial growth as 
lecithin would be then more accessible to the bacteria. Autoclaved medium was 
placed in the anaerobic chamber for at least two hours to ensure that the medium fully 
achieved a reduced state before inoculation with bacterial culture. In addition to 
anaerobic chamber, anaerobic jar can be used to generate anaerobic environment for 
culture of E. coprostanoligenes.  
 The yeast extract in BCM could provide a variety of organic nitrogenous 
constituents which would fulfill the general nitrogen requirement; plus, it also 
contains most of the organic growth factors likely to be required by E. 
coprostanoligenes. Sodium thioglycollate, a reducing agent, is necessary as it 
maintains the medium in reduced (deoxygenated) state to facilitate growth of 
anaerobic E. coprostanoligenes. Some other common reducing agents used in 
anaerobic culture include ascorbic acid, cysteine and dithiothreitol (Holland et al., 
1987). On the other hand, resazurin acts as indicator of deoxygenation of growth 
media (Holland et al., 1987). It will change from blue to pink (oxidized) to colorless 





3.3.2 Growth of bacteria 
3.3.2.1 Evaluation of solid plate counting  
As shown in Figure 3.1, as the bacterial culture was diluted, the number of 
colonies formed on solid agar plate was reduced accordingly. This method thus can be 
used to monitor growth of E. coprostanoligenes. Dilution of culture was necessary to 
avoid over-crowding of the colonies on the surface of solidified medium. It was found 
that only plates that contained 30 to 300 colonies should be considered for counting 
from a practical point of view. Colonies usually formed after 24 hours of incubation 
under anaerobic conditions. Surface colonies of E. coprostanoligenes on anaerobic 
plates were fine, round, white and powdery in texture with approximately 0.2 mm in 
diameter (Figure 3.2a to 3.2e).  
Plate count will measure only the living cells in a population, that is, those 
capable of reproduction (Ingraham and Ingraham, 1995). The indirect techniques that 
measure a property of the mass of cells in a population (e.g. turbidity, dry weight or 
metabolic activity) are not applicable for the present study of growth as BCM is a 
cloudy suspension.  
 
3.3.2.2 Growth patterns of E. coprostanoligenes 
 There was no significant difference in growth for the bacterial cultured in 
medium with or without cholesterol (Figure 3.3). This indicated that cholesterol was 
not necessary for growth of E. coprostanoligenes. Our observation agreed with that of 
Freier et al. (1994). 
E. coprostanoligenes culture grew through three distinct and sequential phases: 
the log, stationary and death phases (Figure 3.3). The lag phase characterized by slow 
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Fig 3.1: Solid plate counting as a method to monitor bacterial growth. Number of 
colony was plotted against dilution factor. Vertical bars denote SE (n=3). Growing 
broth culture was spread evenly on agar solidified medium, sealed, inverted and 
incubated at 37 °C overnight under anaerobic condition. Colonies formed were 
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Figure 3.2: Colonies of E. 
coprostanoligenes on agar solidified 
medium at various dilutions: a) 104; 
b) 105; c) 106; d) 107 times dilution. 
Arrow indicates the only colony. e) 





































Fig. 3.3: Growth curve of E. coprostanoligenes cultured in BCM with and without 
cholesterol. Plate counting for viable cells was carried out daily for a period of 7 days. 

















interval. The bacterial culture might have undergone the lag phase within the first 24 
hours. The log phase persisted for three days after which came the stationary phase. 
The bacteria underwent exponential growth during the log phase and achieved a 
population number of approximately 3 × 1012/ml culture. The stationary phase lasted 
for a day before the death phase characterized by a drastic decrease in number of 
viable cells. Doubling time is the period required for cells in a microbial population to 
grow, divide and to produce two new cells for each one that existed before (Ingraham 
and Ingraham, 1995). During the 72-hour log phase, E. coprostanoligenes culture has 
doubled 21 times which was equivalent to a doubling time of approximately 3 hours 
and 25 min, or 0.3 doubling per hour. 
 The bacteria in this study belong to the genus Eubacterium. It is a common 
genus in the intestinal flora (up to 1011 cells/ g of faeces). It has previously been found 
that E. ruminantium and E. aerofaciens constituted up to 7 % of bovine rumen flora 
and 10 % of human faeces, respectively (Holland et al., 1987). 
 
3.3.3 Microscopy study  
 Figure 3.4a and 3.4c show the confocal and transmission electron microscopy 
images of E. coprostanoligenes. The coccobacilloid cells were 0.5 to 0.7 µm in 
diameter and 1 to 1.2 µm in length. They occurred either singly or in pairs. These 
observations agreed well with that reported by Freier et al. (1994). E. 























Fig. 3.4: Microscopy study of E. 
coprostanoligenes. a) Confocal 
microscopy. The arrow indicates a 
coccobacilloid cell. b): Gram stains. 
The arrow indicates a single cell. c): 
Transmission electron microscopy 
showing a bacterium.  
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3.3.4 Factors affecting growth of E. coprostanoligenes 
3.3.4.1 Effect of lecithin  
 The number of bacterial cells increased with increasing lecithin concentration 
and achieved optimal growth at 1 g/l with approximately 5.4×108 cells/ml culture 
(Figure 3.5). This was a 50-fold increase in number of cells compared to growth in 
BCM without lecithin. When lecithin concentration was increased to 5 g/l and greater, 
the culture media became very viscous which consequently resulted in a reduction of 
viable bacteria.  Freier et al. (1994) had reported that lecithin was metabolized in E. 
coprostanoligenes and was required for growth. However, bacterial growth was 
observed in our experiment even when lecithin was not supplied in culture medium. 
This could be due to the presence of any residual lecithin from inoculating culture.  
 The ability of E. coprostanoligenes to utilize lecithin could be conferred by 
lecithinase, which was probably a mixture of phospholipases (Ratledge, 1994). Freier 
et al. (1994) speculated that the product of phospholipase action might alter the 
bacterial membrane thereby increasing the accessibility of cholesterol to cholesterol 
reductase. These metabolites could also affect the micelle structure in which 
cholesterol was imbedded, which in turn increased the availability of cholesterol 
(Freier et al., 1994).  
 
3.3.4.2 Effect of CaCl2 
 Growth of E. coprostanoligenes was not significantly decreased at CaCl2 
below 2.5 g/l and was found to be in the range of 1.6 to 2.4×107 cells/ml culture 
(Figure 3.6). CaCl2 above 2.5 g/l severely reduced bacterial growth. The number of 
viable cells at 10 g/l CaCl2 was only one-sixth of that at 2.5 g/l. Freier et al. (1994) 

































Fig 3.5: Effect of lecithin on growth of E. coprostanoligenes. Vertical bars denote SE 
(n=3). Different letters (above each bar chart) indicate significant difference between 



















































Fig 3.6: Effect of CaCl2 on growth of E. coprostanoligenes. Vertical bars denote SE 
(n=3).  Different letters (above each bar chart) indicate significant difference between 























lecithin which could then function as an activator of phospholipase enabling it to 
undertake lecithin hydrolysis. Flores-Díaz et al. (2004) had also reported that calcium 
ions played a key role in phospholipase in interaction with substrates in Clostridium 
perfringens. 
 
3.3.4.3 Effect of pH  
 There was no significant difference in growth of E. coprostanoligenes from 
pH 6 to 9 which was found to be in the range of 1.7 to 6.7×108 cells/ml culture 
(Figure 3.7a). Cell multiplication was not observed at pH 4 and 10 after 24 hours of 
incubation. On the other hand, Freier et al. (1994) reported optimal growth of E. 
coprostanoligenes at pH 7 to 7.5 and no growth at pH 5.5 or 8. 
 For those media showing growth of bacteria (media of pH 5 to 9), it was 
interesting to find out that the pH were shifted to the range of 6.4 to 7.1 after 24 hours 
of incubation regardless of the starting pH of culture media (Figure 3.7b). The pH 
shifted because E. coprostanoligenes might be releasing acid or alkali during its 
growth. 
 
3.3.5 Aerotolerance of E. coprostanoligenes 
 Growth of E. coprostanoligenes was not significantly affected when the 
bacteria were cultured in media with and without sodium thioglycollate, and under 
aerobic or anaerobic conditions (Figure 3.8). In all cases, the number of bacterial cells 
increased to 1.4 to 2.1×108 cells/ml culture after 24 hours of incubation. E. 
coprostanoligenes remained viable after 60 hours of exposure to ambient air. 
However, BCM incubated under anaerobic condition tended to have approximately 20 
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Fig 3.7: Effect of pH on growth of E. coprostanoligenes. a) Growth of bacteria in 
BCM of various pH. Vertical bars denote SE (n=3). Different letters (above each bar 
chart) indicate significant difference between treatments (one-way ANOVA Tukey’s 
Test, 95 % confidence level). b) pH of BCM before and 24 hours after inoculation of 










































Fig 3.8: Aerotolerance of E. coprostanoligenes cultured in BCM with and without 
sodium thioglycollate, under aerobic or anaerobic conditions. Vertical bars denote SE 
(n=3). No significant difference between treatments was found (one-way ANOVA. 
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thioglycollate would have approximately 25 % more viable cells. Sodium 
thioglycollate above 1 g/l in BCM severely reduced the number of viable E. 
coprostanoligenes by approximately 30 times (Figure 3.9). E. coprostanoligenes was 
reported to survive exposure to air for at least 48 hours (Freier et al., 1994). 
Sodium thioglycollate is a common reducing agent used in anaerobic culture. 
However, preparation of thioglycollate-containing media in the presence of oxygen 
might result in the formation of oxidized products, which may be toxic to some 
anaerobic bacteria (Holland et al., 1987). Hence, it was recommended that the 
reducing agent should be added only after the medium has been deoxygenated. Low-
toxicity cysteine was reported to be an alternative reducing agent in anaerobic culture 
and its slow reducing capability could be enhanced using illumination (Fukushima et 
al., 2002). 
 Aerotolerance of some anaerobic bacteria has been studied (de Macêdo Farias 
et al., 1999; Beerens et al., 2000; Farias et al., 2001). The atmospheric oxygen 
sensitivity of bacterial strains of genus Fusobacterium was heterogeneous (de Macêdo 
Farias et al., 1999). This heterogeneity in oxygen sensitivity could be due to 
difference in the origin of the bacteria (Beerens et al., 2000). It was also reported that 
varying aerotolerance capability was influenced by the isolation site, laboratory 
handling and growth stage. This capability could be important for the adaptation of 
bacteria to the environment (Farias et al., 2001). Hence, the aerotolerance capability 
of E. coprostanoligenes might be conferred by the nature of its isolation site which is 
not strictly anaerobic. 
Mechanisms of aerotolerance in Brachyspira hyodysenteriae (Stanton and 
Sellwood, 1999), Clostridium perfringens (Trinh et al., 2000) and Bacteroides fragilis 





































Fig 3.9: Effect of sodium thioglycollate on growth of E. coprostanoligenes. Vertical 
bars denote SE (n=3). Different letters (above each bar chart) indicate significant 



















hyodysenteriae has been reported to metabolize oxygen through NADH oxidase. The 
NADH oxidase gene has been cloned and characterized (Stanton and Sellwood, 1999). 
An adaptive response to oxidative stress was suggested in Clostridium perfringens in 
which cells at stationary phase exhibited more resistance than cells in mid-exponential 
growth (Trinh et al., 2000). In addition, Bacteroides fragilis was shown to induce an 
array of genes including genes for catalase and superoxide dismutase producing more 
than 28 proteins when subjected to oxidative stress (Rocha et al., 2003). A regulator, 
OxyR, was identified to respond quickly to oxidative stress inducing the oxidative-
stress-response genes. This phenomenon was considered as a protective mechanism 
and metabolic adaptation (Rocha et al., 2003). The ability of E. coprostanoligenes to 
survive when exposed to oxygen might indicate the presence of such mechanisms. 
 
3.4 Concluding Remarks 
E. coprostanoligenes was successfully cultured and maintained in BCM. Solid 
plate counting, which indicates the number of viable cells, was found to be a reliable 
method to monitor the growth of these bacteria. E. coprostanoligenes was found to 
undergo three days of exponential growth before it reached stationary and death 
phases. In addition, cholesterol was found to have no effect on its growth.  
Colonies of E. coprostanoligenes on agar were fine, round, white and powdery 
in texture. Confocal and transmission electron microscopy revealed that the bacteria 
were coccobacilloid cells of 0.5 to 0.7 µm in diameter and 1 to 1.2 µm in length. The 
cells were gram positive. These features of E. coprostanoligenes agreed with the 
observation of Freier et al. (1994). 
Growth of E. coprostanoligenes was affected by lecithin, CaCl2 and pH of 
culture medium. The number of bacterial cells increased with increasing lecithin 
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concentration and achieved optimum at 1 g/l with approximately 5.4×108 cells/ml 
culture. No significant difference in growth was found for bacteria cultured in 
medium of CaCl2 below 2.5 g/l, and in medium of pH 6 to 9. E. coprostanoligenes 
was also found to survive when exposed to ambient air for at least 60 hours. 
The observations have provided useful information on the growth patterns and 
characteristics of E. coprostanoligenes and will enable us to manipulate the bacteria 
better. Further studies, however, are essential in order to comprehend lecithin 
metabolism and roles of various factors in growing E. coprostanoligenes. 

































4 CHOLESTEROL REDUCTION ACTIVITY OF E. COPROSTANOLIGENES 
 
4.1 Introduction 
 E. coprostanoligenes was found to be able to convert cholesterol to 
coprostanol (Freier et al., 1994). This reaction involves the saturation of C5=C6 
double bond of cholesterol to form coprostanol. As the latter is poorly absorbed by 
human intestinal system (Bhattacharyya, 1986), E. coprostanoligenes holds promise 
for use in treating hypercholesterolemia. Knowledge of cholesterol reduction activity 
in E. coprostanoligenes is necessary for its future application. To date, cholesterol 
reduction activity in these bacteria was investigated using radiolabeled cholesterol 
incorporated with thin layer chromatography (Freier et al., 1994; Li et al., 1995b). 
The method is laborious and poses certain harm as radioisotope is involved. 
 The objective of this chapter is to develop a simple, accurate and reliable 
method to study cholesterol reduction activity. In doing so, the factors affecting the 
cholesterol reduction activity can be investigated. 
 
4.2  Materials and Methods 
4.2.1 Cholesterol measurement using Infinity® Cholesterol Reagent 
 
(a) cuvette method 
Cholesterol sample (10 µl) was added to 1 ml of Infinity® Cholesterol Reagent 
(Sigma Diagnostics®), mixed well and incubated at 37 °C in water bath for 5 min. 
Absorbance was then measured at 500 nm (DU® 640B, Beckman, U.S.A.). Calibration 




(b) microtiter plate method 
 Cholesterol samples (10 µl) were added to 200 µl of Infinity® Cholesterol 
Reagent in a microtiter-plate well, mixed well and incubated at 37 °C in ELISA 
(SPECTRAMAX 340, Molecular Devices) reader for 5 min. Absorbance was then 
measured at 500 nm using ELISA reader. Calibration was performed using 
Cholesterol Calibrators at 1, 2 and 4 g cholesterol/l.  
 
4.2.2 Analysis of cholesterol reduction using thin layer chromatography (TLC) 
 Cholesterol, coprostanol, 5-cholesten-3-one, 4-cholesten-3-one and coprostan-
3-one of concentrations 0.1 to 5 mg/ml were prepared using chloroform: methanol 
(2:1, v/v) as solvent. Silica gel TLC plates were used without any pretreatment. Sterol 
of each concentration was then applied on TLC plates 2 cm from the bottom of the 
plates. Elution was carried out in glass tanks filled with approximately 50 ml of 
hexane: ethyl acetate (80:20, v/v). TLC was stopped after the solvent front had 
traveled 16 cm, which required about 70 min. The plates were sprayed with 10 % (v/v) 
sulfuric acid in 50 % (v/v) methanol followed by heating at 100 °C for 8 min to detect 
the sterols. Relative mobility, Rm, was calculated based on distance traveled by sterol 
divided by distance traveled by solvent front. 
 
4.2.3 Analysis of cholesterol reduction using gas chromatography (GC)  
HP-5 column (Agilent J&W, 30m × 0.32 mm i.d. × 0.25 µm) with 
polysiloxane stationary phase was installed to GC machine (HP 5890 series II) 
equipped with flame ionization detector. Injector and detector temperatures were set 
at 280 and 300 °C, respectively. Oven temperature was maintained isothermally at 
230 °C. Helium carrier gas was maintained at 1.7 ml/min. Cholesterol, coprostanol, 5-
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cholesten-3-one, 4-cholesten-3-one and coprostan-3-one at 1 mM in chloroform: 
methanol (2:1, v/v) were prepared separately. These sterol standards (0.5 µl) were 
then injected consecutively for GC analysis. Analysis was carried out in triplicates. 
Sterols were identified as peaks on chromatograms. Retention time is the time taken 
for sterol to appear as peak on chromatogram. Relative retention time, Rt, was 
calculated based on the retention time of each sterol divided by the retention time of 
cholesterol. Hence, retention time of cholesterol was taken as 1. As for the calibration 
of cholesterol and coprostanol, these sterols were dissolved separately in chloroform: 
methanol (2:1, v/v) at concentrations ranging from 0 to 2.5 mM and 0 to 1 mM, 
respectively. Sterol solutions (0.5 µl) were then injected consecutively for GC 
analysis. Calibration curves were plotted with area under peak against amount of 
sterol.  
 
4.2.4 Cholesterol reduction activity of E. coprostanoligenes 
 BCM containing 1 mM cholesterol was prepared and autoclaved. Ten ml of 
medium was dispensed in a tube and inoculated with 1 ml of 24-hour-old culture 
(approximately 106 cells). The culture was incubated at 37 °C under anaerobic 
conditions. Bacterial culture (1 ml) was withdrawn from the tube and extracted twice 
with two volumes of chloroform: methanol (2:1, v/v). The combined organic extracts 
were concentrated to 500 µl for analysis using GC according to the procedure outlined 
in section 4.2.3. The test was carried out for a period of 5 days in triplicate. 
Cholesterol and coprostanol in a sample were identified by comparing their 
respective retention times with that of standards obtained in section 4.2.3. For 
subsequent analysis, the interpretation of a chromatogram was based on “internal 
normalization” in which the areas under “cholesterol peak” and “coprostanol peak” in 
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a chromatogram were summed up and “normalized” to 100 %. Cholesterol and 




It was assumed that response factors for cholesterol and coprostanol were 
identical; the area of each peak divided by the sum of the areas of all peaks in the 
chromatogram represented the concentrations of the compounds directly. 
 
4.2.5 Effects of lecithin, CaCl2 and pH on cholesterol reduction activity 
BCM containing 1 mM cholesterol with a) lecithin concentrations varying 
from 0 to 10 g/l; b) calcium chloride concentrations varying from 0 to 10 g/l; and c) 
pH adjusted to 4, 5, 6, 6.5, 7, 7.5, 8, 9 and 10, were prepared and autoclaved, 
respectively. The media were then reduced in the anaerobic chamber for 2 hours. Ten 
ml each of these media was dispensed in a tube, respectively, and inoculated with 1 
ml of 24-hour-old culture (approximately 106 cells) and incubated at 37 °C in 
anaerobic chamber. One ml of bacterial culture was withdrawn from the tube after 24 
hours of incubation for sterol extraction and analysis using GC. Each test was carried 
out in triplicate. 
 
4.2.6 Cholesterol reduction activity of E. coprostanoligenes under aerobic 
condition 
BCM of 1 mM cholesterol with and without sodium thioglycollate were 
prepared and autoclaved. For each medium, one set was reduced in anaerobic 
chamber (anaerobic condition) with the other set exposed to ambient air (aerobic 
Cholesterol (%) 
Area under cholesterol peak 
Area under cholesterol peak + Area under coprostanol peak 
= × 100 % 
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condition) by shaking in a shaker incubator for two hours before being inoculated 
with E. coprostanoligenes. Ten ml of media in the anaerobic chamber and shaker 
incubator was dispensed into tube, respectively, and inoculated with 1 ml of 24-hour-
old culture (approximately 106 cells) and incubated at 37 °C. One ml of the bacterial 
culture was withdrawn from each tube at 12 hours interval for 60 hours followed by 
sterol extraction and analysis using GC. Each test was carried out in triplicate. 
 
4.3 Results and Discussion 
4.3.1 Development and optimization of analytical method for cholesterol 
reduction activity 
4.3.1.1 Cholesterol measurement using Infinity® Cholesterol Reagent 
Cholesterol measurements using Infinity® Cholesterol Reagent in cuvette and 
microtiter plate were compared. Cholesterol concentrations as low as 10 µg could be 
measured, with every 0.1 change in absorbance corresponded to approximately 0.6 µg 
of cholesterol (Figure 4.1a). On the other hand, analysis carried out in microtiter plate 
offered a ten times higher sensitivity (Figure 4.1b), and it used up only one-fifth of the 
amount of reagent required in cuvette assays for the same measurement.  In addition, 
measurement using microtiter plate had a higher throughput than cuvette because 96 
samples could be measured simultaneously. Therefore, cholesterol measurement using 
Infinity® Cholesterol Reagent in microtiter plate is recommended.  
Cholesterol analysis was generally accomplished using a three-enzyme assay 
and indicator method devised by Richmond (1973). The first enzyme, cholesterol 
esterase, freed the esterified cholesterol present in a sample. The free cholesterol was 
then subjected to oxidation by the second enzyme, cholesterol oxidase, releasing 





















































Fig. 4.1: Cholesterol calibration curves using Infinity® Cholesterol Reagent based on 
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hydrogen peroxide produced. Reactivation of the peroxidase through oxidation of an 
indicator molecule produced a chromogen which, when measured, facilitated an 
indirect estimation of total cholesterol. Infinity® Cholesterol Reagent was based on 
the formulation of Allan et al. (1974) (Figure 4.2). The reagent allowed the direct 
measurement of the amount of cholesterol reduced in cholesterol-reduction 







Fig 4.2: Reaction of Infinity® Cholesterol Reagent. CE= Cholesterol esterase; CO= 




4.3.1.2 Analysis of cholesterol reduction using TLC 
 Cholesterol and coprostanol were resolved on TLC plate eluted with hexane: 
ethyl acetate (80:20, v/v) (Figure 4.3). The proposed intermediates for cholesterol-
reduction pathway in E. coprostanoligenes, 5-cholesten-3-one, 4-cholesten-3-one and 
coprostanon-3-one (Ren et al., 1996), were also resolved (Figure 4.3). Cholesterol and 
coprostanol of as low as 1 µg could be detected on TLC (Table 4.1). The sensitivity of 
cholesterol, coprostanol and the intermediates is tabulated in Table 4.1. 5-Cholesten-
3-one, 4-cholesten-3-one and coprostan-3-one less than 100, 10 and 50 µg, 
respectively could not be detected.  
Tan et al. (1970) reported that coprostanol was not well separated from 
cholesterol on TLC eluted with solvent systems such as chloroform: ether (9:1, v/v), 






















Fig 4.3: TLC of cholesterol, coprostanol, 5-cholesten-3-one, 4-cholesten-3-one and 
coprostan-3-one eluted with hexane: ethyl acetate (80:20, v/v). a, b, c, d and e are 

























Table 4.1: Relative mobility and sensitivity of cholesterol, coprostanol, 5-cholesten-3-
one, 4-cholesten-3-one and coprostan-3-one eluted with hexane: ethyl acetate (80:20, 
v/v) on TLC.  
 
Substance Relative mobility, Rm Sensitivity (µg) 
Cholesterol 0.47 ≥ 1 
Coprostanol 0.59 ≥ 1 
4-Cholesten-3-one 0.68   ≥ 10 
5-Cholesten-3-one 0.84     ≥ 100 












(4:1, v/v). On the other hand, Domnas et al. (1983) found that hexane/ ethyl acetate 
(9:1, v/v) was most effective in resolving cholesterol and coprostanol. A TLC plate, 
when pre-eluted with diethyl ether and using chloroform as developing solvent, was 
found to resolve cholesterol and coprostanol (Bethell et al., 1994). In a study of 
cholesterol utilization by mycobacterium, cholesterol degradation could be clearly 
shown on TLC plates eluted with cyclohexane/chloroform (1:1, v/v) (Av-Gay and 
Sobouti, 2000). However, all the TLC methods discussed above had not studied the 
resolution of cholesterol and coprostanol together with the three proposed 
intermediates, which was already achieved in our method. 
 The TLC method could be utilized to study cholesterol reduction activity in E. 
coprostanoligenes. One drawback of qualitative TLC is that the absolute amount of 
substances on TLC plates cannot be determined as spots were difficult to quantify. In 
addition, the spots did not remain for a long time and would fade off after 1 day. 
 
4.3.1.3 Analysis of cholesterol reduction using GC 
Cholesterol, coprostanol and coprostan-3-one were resolved as single and 
sharp peaks on GC chromatogram (Figure 4.4).  On the other hand, 5-cholesten-3-one 
and 4-cholesten-3-one appeared as a single peak. Attempts to resolve these two 
compounds by reducing the flow rate from 1.7 to 1 ml/ min and oven temperature 
from 230 to 200 °C were not successful.  This might be attributed to highly similar 
structure between the two compounds, which differs only in the position of C=C 
double bond at C-5 and C-4, respectively. In the GC, coprostan-3-one was eluted first, 
followed by coprostanol, cholesterol and lastly the two cholesten-3-ones. The 
retention time and relative retention time (Rt) of these sterols are tabulated in Table 








Fig 4.4: GC chromatogram showing peaks of sterol standards. Peaks a, b, c and d are 
coprostan-3-one, coprostanol, cholesterol and choleste-3-ones (4-cholesten-3-one and 
5-cholesten-3-one), respectively. 4-Colesten-3-one and 5-cholesten-3-one were not 
resolved. 0.5 µl of sterol standards containing 1 mM of each sterol were injected to 
HP5890 Series II gas chromatography and resolved using HP-5 column. Injector/ 
detector temperature: 280 °C/ 300 °C; Oven temperature: isothermal 230 °C.  Helium 



















Table 4.2: Relative retention times of cholesterol, coprostanol, 5-cholesten-3-one, 4-
cholesten-3-one and coprostan-3-one resolved with HP-5 capillary column in GC. 
Injector/ detector temperature: 280 °C/ 300 °C; Oven temperature: isothermal 230 °C.  
Helium carrier gas: 1.7 ml/min. 
 
Retention  Substance 
Time (min) 
Relative 
retention time, Rt 
Coprostanon-3-one 11.27 0.72 
Coprostanol 14.27 0.91 
Cholesterol 15.75 1.00 
4-Cholesten-3-one 21.39 1.36 














these two concentration ranges: 0 to 2.5 nmol and 0 to 1 nmol, respectively (Figure 
4.5). The method developed is sensitive as it can detect cholesterol and coprostanol of 
as low as 0.1 nmol. 
Successful separation of cholesterol and coprostanol based on GC required a 
high degree of efficiency because the two sterols differ in their molecular structure 
merely by the presence of a double bond (Tan et al., 1970). Cholesterol and 
coprostanol were only partially resolved in glass column packed with 3 % SE-30 on 
100-140 mesh Gas Chrom P (Rosenfeld et al., 1961) and 100-120 mesh Gas Chrom Q 
(Hassett and Lee, 1977). An almost complete resolution between cholesterol and 
coprostanol was achieved with the GC method developed by Tan et al. (1970) using 
combined OVTM-1 and OFTM-1 phases on a single column. GC equipped with glass 
column packed with 1.5% OVTM 17 on Chromosorb® W 80/100 mesh was used in the 
study of microbial degradation of sterols (Marsheck et al., 1972). 
The GC method developed by Marriott et al. (1998) had greatly improved the 
separation and resolution of cholesterol, coprostanol and plant sterols. The protocol 
involved supercritical fluid extraction, derivatization and GC analysis using a BPX5 
capillary column and electron capture detector. Complete separation was also 
achieved using HiCap CBP-1 capillary column (Yamaga et al., 2002) with 19-
hydroxycholesterol as the internal standard.  
Each compound analyzed with GC could be quantified. This would be useful 
in studying the conversion of cholesterol into coprostanol as well as the kinetics of 
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Fig. 4.5: GC calibration curves for a) cholesterol, and b) coprostanol. Vertical bars 




































4.3.1.4 Summary of methods development  
 A summary of spectrophotometric and chromatographic methods for 
cholesterol-reduction study is shown in Table 4.3. Spectrophotometric and 
chromatographic approaches were investigated and compared for their suitability in 
cholesterol reduction study. Spectrophotometric method utilizing the Infinity® 
Cholesterol Reagent is useful because it is simple, direct and quantitative. However, 
the reagent cannot measure coprostanol, the end product of cholesterol reduction in E. 
coprostanoligenes. From the perspective of this project, it is seen as a disadvantage of 
using Infinity® Cholesterol Reagent. 
TLC and GC are able to detect cholesterol, the proposed intermediates and 
coprostanol in a sample. TLC has better throughput because as many as 20 samples 
can be analyzed at any one time. In contrast, samples in GC have to be run 
consecutively, which greatly reduces its efficiency. In our study, the time taken for 
each sample in TLC was lesser compared to GC even though post-elution treatment 
was required for spots visualization. In TLC, each sample took approximately 6 min 
when considering 70 and 50 min for running and post-elution treatment, respectively. 
Analysis of one sample alone in GC required approximately 25 min.  
Despite a lower efficiency and longer analysis time in GC, it represented a 
better choice in cholesterol reduction study because each substance in a sample could 
be quantified. With quantitative values, results obtained would be more accurate and 









Table 4.3: Summary of spectrophotometric and chromatographic methods for cholesterol-reduction study 
  Detectable substance       
Analysis   4-Cholesten-3-one    






Spectrophotometry^ Yes No No Yes 1 5 
       
Chromatography       
TLC Yes Yes Yes No 1 6˜ 
GC Yes Yes Yes Yes 0.2 25 
 
*Based on coprostanol 
^Infinity® Cholesterol Reagent 






4.3.2 Cholesterol reduction activity of E. coprostanoligenes 
E. coprostanoligenes was found to reduce cholesterol when cultured in BCM 
containing 1 mM cholesterol. Using GC, it was observed that cholesterol reduction was 
accompanied with coprostanol formation (Figure 4.6a). Approximately 65 % of the 
conversion took place during the first two days of culture. Cholesterol reduction 
continued from day-3 to day-5 but the amount of conversion was not significant, with 
another 3 % of cholesterol being reduced. Active cholesterol reduction reaction took 
place at the exponential growth phase (Figure 3.3). Our findings re-affirmed the 
cholesterol reduction ability of E. coprostanoligenes reported by Freier et al. (1994). 
Conversion of cholesterol to coprostanol involves the reduction of the double 
bond at C-5 of the A ring of cholesterol and it is the most common reduction reaction that 
occurs with cholesterol (Hylemon and Harder, 1999). Anaerobic faecal bacteria from 
human intestine had been found to modify bile acids and steroids by deconjugation, 
dehydration, reduction and dehydroxylation (Holland et al., 1987). Besides E. 
coprostanoligenes, a denitrifying bacterium strain 72Chol was found to be able to convert 
cholesterol completely under anaerobic condition to carbon dioxide (Hylemon and 
Harder, 1999).  
Biotransformation of monoterpenes, bile acids, and other isoprenoids in anaerobic 
bacteria has been reviewed (Hylemon and Harder, 1999). Bile acids that were not 
reabsorbed through enterohepatic circulation were exposed to up to 400 different kinds of 
mostly obligate anaerobes in the colon. The predominant species are members of genera 
Bacteroides, Fusobacterium, Eubacterium and Clostridium which generated 15 to 20 

















                  
Fig. 4.6: Cholesterol reduction activity of E. coprostanoligenes at 1 mM of cholesterol. a) 
Graph showing the conversion of cholesterol to coprostanol. Vertical bars denote SE 
(n=3). b) GC chromatogram showing the action of E. coprostanoligenes (i) before, and (ii) 
after the inoculation in BCM. Peaks a and b are cholesterol and coprostanol respectively. 


















The conversion of cholesterol to coprostanol was thought to be carried out by 
cholesterol reductase (Dehal et al., 1991), which is yet to be characterized. However, 
many other steroid transforming reactions and enzymes had been studied in anaerobic 
bacteria particularly in the genus Eubacterium (Feighner et al., 1979; Glass and Burley, 
1984; Winter et al., 1984; Oda et al., 2001). For example, 21-dehydroxylase, extracted 
from Eubacterium lentum, is known to catalyze the conversion of 11-deoxycorticosterone 
to progesterone (Feighner et al., 1979). A 16- dehydroprogesterone reductase was 
assumed to be involved in the biotransformation of 16-dehydroprogesterone to 
isoprogesterone in intestinal Eubacterium sp. 144 (Glass and Burley, 1984). Another 
example is 7β-Hydroxysteroid dehydrogenase produced by Eubacterium aerofaciens, 
which was reported to reduce a double bond in methyl 7-ketolithocholate to methyl 
ursodeoxycholate (Oda et al., 2001). All these examples may indicate the possible 
existence of a sterol reductase in E. coprostanoligenes. 
  
4.3.3 Factors affecting cholesterol reduction activity 
4.3.3.1 Effect of Lecithin  
 Cholesterol reduction activity, as indicated by coprostanol production, increased 
with increasing lecithin concentration. In the absence of lecithin, conversion of 
cholesterol to coprostanol was not detected (Figure 4.7). Maximum coprostanol 
production was achieved when lecithin was increased to 5 g/l, which was up to 43 % 
increase compared to lecithin at 1 g/l (Figure 4.7). When the lecithin concentration was 
doubled to 10 g/l, the media became more viscous, but no further increase in coprostanol 


































Fig 4.7: Effect of lecithin on cholesterol reduction activity of E. coprostanoligenes. 
Vertical bars denote SE (n=3). Numbers (above each bar chart) indicate relative activity 
with respect to that of 1 g/l (taken as 1). Different letters (above each bar chart) indicate 





















As discussed in Chapter 3, optimal bacterial growth was actually achieved at a 
lecithin concentration of 1 g/l. Lecithin concentration above that resulted in a reduction in 
the number of viable cells (Figure 3.5). This thus gives rise to the speculation that the 
increased cholesterol reduction at lecithin above 1 g/l was the effect of increased lecithin. 
Freier et al. (1994) had suggested that increased lecithin could increase lecithin digestion 
by the bacteria which could in turn increase cholesterol reduction activity. 
 
4.3.3.2 Effect of CaCl2 
 Increasing CaCl2 concentration caused an increase in cholesterol reduction with 
the optimum achieved at 1 g/l where 60 % of cholesterol was reduced. A further 
increased in CaCl2 concentration to 5 g/l showed no significant increase in cholesterol 
reduction (Figure 4.8). Cholesterol reduction was severely affected at 10 g/l CaCl2, with 
only 25 % of cholesterol being reduced. As discussed in Chapter 3, growth of E. 
coprostanoligenes was reduced at CaCl2 above 2.5 g/l (Figure 3.6). However, this 
reduction in growth did not affect the cholesterol reduction at 5 g/l CaCl2. 
 Freier et al. (1994) suggested that calcium ions supplied a net positive charge to 
lecithin which functioned as activator of phospholipase for lecithin hydrolysis. The 
metabolites of lecithin hydrolysis in turn played a role in cholesterol reduction. In present 
study, CaCl2 at 1 g/l could be just optimal to supply the net positive charge. CaCl2 



































Fig 4.8: Effect of CaCl2 on cholesterol reduction activity of E. coprostanoligenes. 
Vertical bars denote SE (n=3). Numbers (above each bar chart) indicate relative activity 
with respect to that of 1 g/l (taken as 1). Different letters (above each bar chart) indicate 





















4.3.3.3 Effect of pH  
 Cholesterol reduction activity was found to take place between pH 5 to 9. Optimal 
cholesterol reduction took place when BCM was adjusted to pH 7, with approximately 75 
% of cholesterol undergoing reduction (Figure 4.9). This observation agreed with that 
reported by Freier et al. (1994). While the activity was reduced almost by half when pH 
was adjusted to 5 from 7, no significant difference in cholesterol reduction was found in 
BCM at pH 7, 7.5 and 8. In addition, no cholesterol reduction was detected at pH 4 and 
10 (Figure 4.9), where bacterial growth was not evident (Figure 3.7). The discrepancy of 
the present findings with that of Freier et al. (1994) who found no cholesterol reduction 
taking place at pH 5.5 or 8 suggest that E. coprostanoligenes may be stable enough over a 
range of pH values to carry out cholesterol reduction. The stability of E. 
coprostanoligenes to carry out cholesterol reduction reaction over a wide range of pH is 
an advantage for its future application. 
 
4.3.4 Cholesterol reduction activity of E. coprostanoligenes under aerobic 
condition 
 No significant difference was found in cholesterol reduction for E. 
coprostanoligenes cultured in BCM with or without sodium thioglycollate, either under 
aerobic or anaerobic conditions. However, bacterial culture in BCM without sodium 
thioglycollate tended to reduce approximately 10 % more cholesterol than those cultured 


































Fig 4.9: Effect of pH on cholesterol reduction activity of E. coprostanoligenes. Vertical 
bars denote SE (n=3). Numbers (above each bar chart) indicate relative activity with 
respect to activity at pH 7 (taken as 1). Different letters (above each bar chart) indicate 























































Fig 4.10: Cholesterol reduction activity in E. coprostanoligenes cultured in BCM with 
and without sodium thioglycollate, under aerobic and anaerobic conditions. Vertical bars 
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4.4  Concluding Remarks 
 Spectrophotometric determination of cholesterol reduction activity using Infinity® 
Cholesterol Reagent and chromatographic (TLC and GC) approaches in detecting 
cholesterol reduction activity were developed and compared. Each method had its 
advantages and disadvantages. After considering for reliability and accuracy, GC was 
evaluated as the best method despite requiring a longer analysis time. 
 E. coprostanoligenes were found to convert 65 % of cholesterol to coprostanol in 
BCM containing 1 mM cholesterol. This re-affirmed the cholesterol reduction property of 
E. coprostanoligenes reported by Freier et al. (1994). Lecithin, CaCl2 and pH of medium 
were found to affect cholesterol reduction activity. The activity increased with increasing 
lecithin concentration and maximum cholesterol reduction was achieved at 5 g/l of 
lecithin. CaCl2 of 1 g/l was found to be optimum for cholesterol reduction activity. In 
addition, the reaction could occur over a wide range of pH from 5 to 9, as well as in 
aerobic condition. 
The results obtained from this chapter have provided useful information on the 
cholesterol reduction properties of E. coprostanoligenes and formed a fundamental for its 
future application. Further studies, however, are essential in order to comprehend the 









5 PROPERTIES OF PUTATIVE CHOLESTEROL REDUCING ENZYME(S) 
 
5.1 Introduction 
 Literature on cholesterol reduction reaction of E. coprostanoligenes has been 
scarce since its isolation and characterization (Freier et al., 1994; Li et al., 1995b; Ren et 
al., 1996). An enzyme designated as cholesterol reductase was suggested to carry out the 
conversion of cholesterol to coprostanol in E. coprostanoligenes (Dehal et al., 1991). To 
date, it has not been characterized. Although the mechanisms underlying bacterial 
cholesterol reduction have been studied (Schoenheimer et al., 1935; Rosenfeld et al., 
1955; Björkhem and Gustafsson, 1971; Ren et al., 1996), two pathways of cholesterol 
reduction, the direct and the indirect pathways were proposed to take place in E. 
coprostanoligenes (Ren et al., 1996). In the direct pathway, cholesterol is converted 
directly to coprostanol. On the other hand, in the indirect pathway, it is transformed via 5-
cholesten-3-one, 4-cholesten-3-one and coprostan-3-one to coprostanol. 
 The objectives of this chapter are to study the properties of putative cholesterol 
reducing enzyme(s) as well as cholesterol reduction pathway in E. coprostanoligenes.  
  
5.2 Materials and Methods 
5.2.1 Kinetics of cholesterol reduction activity 
 BCM containing cholesterol of concentrations ranging from 0 to 2 mM were 
prepared (50 ml of each concentration) and autoclaved. The media were then reduced in 
an anaerobic chamber for 2 hours. The different media were dispensed into 10 ml per 
tube, respectively in triplicate, and inoculated with 1 ml of 24-hour-old culture 
 70
(containing approximately 106 cells) and incubated at 37 °C in anaerobic chamber. For 
each concentration, 1 ml of culture was withdrawn daily for sterol extraction and analysis 
using GC. Extraction and analysis were carried out for a period of 5 days.  
 
5.2.2 Induction of putative cholesterol reducing enzyme(s) 
E. coprostanoligenes was sub-cultured ten times in BCM without cholesterol. At 
every sub-culture, 200 ml fresh BCM were inoculated with 20 ml of 2-day-old culture 
(containing approximately 107 cells/ml). For the eleventh sub-culture, bacterial culture 
was incubated at 37 °C anaerobically for 24 hours followed by the addition of cholesterol 
suspension (193 mg of cholesterol and 97 mg of lecithin were boiled and mixed in 100 ml 
milli-Q water as stock cholesterol suspension of 5 mM) at a final concentration of 1 mM. 
The bacterial culture (1 ml) was then withdrawn at 0, 0.5, 1 and 2 hours of incubation for 
sterol extraction and analysis using GC. The test was carried out in triplicate. 
 
5.2.3 Secretion of putative cholesterol reducing enzyme(s) 
 BCM (50 ml) with (1 mM) and without cholesterol were prepared and autoclaved. 
The media were then reduced in an anaerobic chamber for 2 hours. The different media 
were dispensed into 10 ml per tube in triplicate and inoculated with 1 ml of 24-hour-old 
culture (containing approximately 106 cells) and incubated at 37 °C in anaerobic chamber. 
After 24 hours of incubation, tubes of culture were centrifuged at 14,000 g for 20 min. 
Supernatants harvested from culture with and without cholesterol were labeled as 
“Supernatant W” and “Supernatant W/O”, respectively.  Cholesterol suspension and 
NADH (10 mg of NADH was dissolved in 2.56 ml of milli-Q water to form 5 mM 
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NADH solution) were then added to both types of supernatants at a final concentration of 
1 mM of cholesterol and NADH. The mixtures were incubated at 37 °C under anaerobic 
condition. After 24 hours of incubation, 1 ml of mixture was withdrawn for sterol 
extraction and analysis using GC.  Bacterial culture (1 ml) from BCM containing 1 mM 
of cholesterol was used as control.  
 
5.2.4 Elucidation of cholesterol reduction pathway  
Sterol media (50 ml) containing 1 mM 4-cholesten-3-one, 5-cholesten-3-one or 
coprostan-3-one were prepared according to the procedure outlined in Section 3.2.1 by 
replacing cholesterol with the respective sterols. The prepared media were dispensed into 
10 ml per tube in triplicate and inoculated with 1 ml of 24-hour-old culture (containing 
approximately 106 cells) and incubated at 37 °C in an anaerobic chamber. From each type 
of sterol medium, 1 ml of culture was withdrawn daily for a period of 4 days for sterol 
extraction and analysis using GC. 
 
5.2.5 Inhibition of putative cholesterol oxidase activity  
 Cholesterol oxidase inhibitors (tridemorph, fenpropidin and fenpropimorph) were 
purchased from Sigma-Aldrich®. BCM (150 ml) containing 1 mM cholesterol was 
prepared and autoclaved. The media were then dispensed into 3 bottles of 50 ml/bottle 
and reduced in an anaerobic chamber for 2 hours. Tridemorph was then added to the 
media in the three separate bottles at three different concentrations of 50 mg/L, 100 mg/L 
and 200 mg/L, respectively. Medium in each bottle was then dispensed into 10 ml per 
tube in triplicate and inoculated with 1 ml of 24-hour-old culture (containing 
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approximately 106 cells) and incubated at 37 °C in an anaerobic chamber. After 24 hours 
of incubation, 1 ml of culture was withdrawn from each tube for sterol extraction and 
analysis using GC. Plate counting for viable cells was done at the same time in triplicate 
for each concentration. The same procedures were repeated for fenpropidin or 
fenpropimorph. Bacterial culture without inhibitor was used as control. 
 
5.3 Results and Discussion 
5.3.1 Kinetics of cholesterol reduction activity 
The kinetics of cholesterol reduction activity in E. coprostanoligenes was 
investigated in the present study. Cholesterol reduction activity was found to increase 
with increasing cholesterol concentration (Figure 5.1). Active cholesterol reduction took 
place during the first two days of incubation corresponding to the exponential growth 
phase of the bacteria after which the reduction activity tapered off. In our study, 73.6 % 
and 42.5 % of cholesterol were reduced in BCM containing 0.25 and 2 mM cholesterol, 
respectively. Freier et al. (1994) had reported the conversion of up to 90 % of cholesterol 
to coprostanol in BCM containing 5.2 mM cholesterol.  
Cholesterol was not completely reduced even when incubation was extended to 5 
days most likely because the bacteria have entered death phase after 4 days of culture and 
the number of cells would have declined sharply. As the growth of E. coprostanoligenes 
was not affected by cholesterol (Figure 3.3), the difference in the rate of cholesterol 
reduction is likely to be a direct effect of different in cholesterol concentrations.  
The Lineweaver-Burk plot was constructed based on the cholesterol reduction 
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Fig. 5.1: Kinetics of cholesterol reduction of E. coprostanoligenes at different cholesterol 
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Fig. 5.2: Lineweaver-Burk plot for cholesterol reduction in E. coprostanoligenes. V and 
[S] denote initial velocity of cholesterol reduction and concentration of cholesterol, 











y-intercept = 1/Vmax 
x-intercept = -1/Km 
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reduced/h. It was found that any further increase in cholesterol concentration did not 
increase the rate of cholesterol reduction. Km for cholesterol reduction in E. 
coprostanoligenes was calculated to be 1 mM cholesterol. 
 
5.3.2 Induction of putative cholesterol reduction enzyme(s) 
 The enzyme(s) responsible for cholesterol reduction appeared to be constitutively 
produced. This is postulated based on the fact that cholesterol reduction activity has 
already taken place as early as 30 min of incubation (Figure 5.3). The activity of 
inducible enzyme would only be detected 3 to 6 hours after the addition of substrate 
(Glass and Burley, 1984).  The reduction reaction appeared to proceed at a constant rate 
with 50 µM of cholesterol being reduced at 30 min and making up to 170 µM of 
cholesterol reduced in 2 hours. The present study showed that E. coprostanoligenes had 
not lost its capability for cholesterol reduction after being sub-cultured 10 times in 
cholesterol-free media.  
  
5.3.3 Secretion of putative cholesterol reduction enzyme(s) 
 Cholesterol reducing enzyme(s) appeared to be produced and retained 
intracellularly. Only 8 to 9 % of cholesterol was reduced in supernatants W and W/O 
compared to almost 60 % reduction in bacterial culture (Figure 5.4). Plate counting with 
the supernatants after 24-hour of incubation revealed the presence of E. 
coprostanoligenes at a magnitude of hundreds to a thousand cells. The insignificant 
cholesterol reduction in the supernatants could be attributed to the residual cells retained. 





























Fig. 5.3: Constitutive secretion of cholesterol reducing enzyme(s) by E. 





















































Fig. 5.4: Intracellular secretion of cholesterol reducing enzyme(s) by E. 
coprostanoligenes. Supernatants W and W/O were harvested from bacterial culture with 
and without cholesterol, respectively. Vertical bars denote SE (n=3). Numbers (above 
each bar chart) indicate concentrations. Different letters (above each bar chart) indicate 



















significant difference in cholesterol reduction was observed in supernatants obtained 
from media with (Supernatant W) and without (Supernatant W/O) cholesterol (Figure 
5.4). 
Enzyme that converts cholesterol to coprostanol has not been characterized. Since 
the cholesterol reducing enzyme(s) of E. coprostanoligenes was observed to be not 
secreted extracellularly, we postulated that the cholesterol reduction reaction took place 
either on the bacterial membrane (by membrane-bound enzyme) or within the bacterial 
cell (by cytoplasmic enzyme). Bacterial cells must be broken in order to isolate the 
enzyme(s). However, we lost the cholesterol reduction activity in our attempts to isolate 
the enzyme(s) using sonication, passage through a French pressure cell or enzymatic 
digestion of the bacterial membrane. The loss of activity could be due to disrupted 
membrane integrity.  
 
5.3.4 Cholesterol reduction pathway of E. coprostanoligenes 
The cholesterol reduction reaction with the intermediates of 5-cholesten-3-one, 4-
cholesten-3-one and coprostan-3-one as intermediates was verified in E. 
coprostanoligenes. Each of these intermediates was converted to coprostanol when 
incorporated in BCM in place of cholesterol (Figure 5.5). The reaction profile appeared 
to follow such a sequence: cholesterol → 5-cholesten-3-one → 4-cholesten-3-one → 
coprostan-3-one → coprostanol. This profile agreed with the indirect pathway of 
cholesterol reduction proposed by Ren et al. (1996). On the other hand, direct conversion 
of cholesterol to coprostanol could not be excluded in view of the fact that the 












































































Fig. 5.5: Reduction of a) 5-cholesten-3-one; b) 4-cholesten-3-one; and c) coprostan-3-one 
to coprostanol by E. coprostanoligenes. The indirect pathway of cholesterol reduction 
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In the reduction of 5-cholesten-3-one and 4-cholesten-3-one, coprostan-3-one was 
first detected followed by coprostanol. The reaction reached steady state after 2 days of 
incubation with a constant pool of coprostan-3-one. In the case of reduction of coprostan-
3-one, there was a transient increase of cholesten-3-ones before it was converted to 
coprostanol.   
 The results suggested the possible roles of enzymes that catalyzed the conversion 
of each intermediate to the subsequent one until coprostanol was formed. In the 
conversion of plant sterol to stanol, various enzymes have been reported for the 
conversion of the intermediates (Li et al., 1996b; Klahre et al., 1998; Noguchi et al., 
1999; Venkatramesh et al., 2003). A scheme for the conversion of plant sterol to stanol 
involving 3 different enzymes was proposed (Figure 5.6) (Venkatramesh et al., 2003). It 
is likely that these enzymes are also present in E. coprostanoligenes.  
Cholesterol oxidase from Brevibacterium sp. was found to have cholesterol 
reduction potential and could reduce up to 85.6 % of cholesterol in egg yolk (Lv et al., 
2002). This enzyme is well characterized to catalyze the conversion of cholesterol to 4-
cholesten-3-one via 5-cholesten-3-one (MacLachlan et al., 2000). It is likely to exist in E. 
coprostanoligenes catalyzing the conversion of cholesterol to 4-cholesten-3-one in the 
indirect pathway of cholesterol reduction.  However, cholesterol oxidase does not convert 
cholesterol to coprostanol. Other enzyme(s) may catalyze the conversion of 4-cholesten-
3-one leading to the formation of coprostanol after the initial action of cholesterol 
oxidase.  
  










Fig 5.6: Proposed scheme for conversion of sterol to stanol in plants. Reactions 1 and 2 
are catalyzed by 3-hydroxysteroid oxidase, whereas reactions 3 and 4 are catalyzed by 











5.3.4 Inhibition of putative cholesterol oxidase activity  
 Tridemorph, fenpropidin and fenpropimorph were reported to inhibit the 
conversion of cholesterol to 4-cholesten-3-one (Hesselink et al., 1990; MacLachlan et al., 
2000). In our experiment, Tridemorph at a concentration of up to 200 mg/l did not affect  
the activity significantly. Fenpropidin and fenpropimorph at 200 mg/l and 100 mg/l, 
respectively were found to reduce cholesterol reduction activity by 28 % (Figure 5.7). 
Plate counting, however, showed that bacterial growth was also inhibited by these 
inhibitors (Figure 5.8). Therefore, we could not confirm whether the depression of 
cholesterol reduction activity was due to the inhibition of cholesterol oxidase activity. 
Further increased of fenpropimorph to 2 g/l did not abolish cholesterol reduction activity 
(27 % remained). Cholesterol in this case might have been converted to coprostanol via 
the direct pathway of cholesterol reduction. 
 
5.4 Concluding Remarks 
Cholesterol reduction activity in E. coprostanoligenes was found to increase with 
increasing cholesterol concentration. Vmax and Km of cholesterol reduction activity in 
these bacteria were calculated to be 14 µM cholesterol reduced/h and 1 mM cholesterol, 
respectively. Cholesterol reducing enzyme(s) was shown to be secreted constitutively and 
intracellularly. Hence, the reaction site for cholesterol reduction was deduced to take 
place either in cytoplasm or bacterial membrane. However, attempts to isolate the 
enzyme(s) by disrupting E. coprostanoligenes cells were not successful.  
The indirect pathway of cholesterol reduction was verified in E. 




































Fig. 5.7: Inhibition of putative cholesterol oxidase activity in E. coprostanoligenes. 
Vertical bars denote SE (n=3). Numbers (above each bar chart) indicate cholesterol 
reduction activity relative to that of control (taken as 1). Asterisk (above each bar chart) 
indicates significant different between treatment and control (one-way ANOVA. Tukey’s 



































































Fig. 5.8: Effect of tridemorph, fenpropidin and fenpropimorph on growth of E. 
coprostanoligenes. Vertical bars denote SE (n=3). Numbers (above each bar chart) 
indicate number of viable cell/ml relative to that of control (taken as 1). Asterisk (above 
each bar chart) indicates significant different between treatment and control (one-way 
























bacteria. However, this postulation could not be confirmed by inhibitor study. Further 
studies, however, are necessary in order to characterize the putative enzyme(s). 































This study is the first detailed investigation on the growth and cholesterol 
reduction activity of E. coprostanoligenes. The investigation began with the development 
of solid plate counting method to monitor growth of the bacteria, together with GC 
method to study its cholesterol reduction activity. Based on these methods, it was found 
that lecithin, CaCl2 and pH of culture medium affected growth and cholesterol reduction 
activity of E. coprostanoligenes differently. The bacteria showed optimal growth at 1 g/l 
of lecithin, 0.5 g/l of CaCl2 and at a wide pH range of 6 to 9. Maximum cholesterol 
reduction was found to take place at 5 g/l of lecithin, 1 g/l of CaCl2 and at pH 7. Besides, 
growth of these cholesterol-reducing bacteria was not induced by cholesterol, thereby 
ruling out the role of cholesterol as an energy source. E. coprostanoligenes was also 
found to survive exposed to ambient air for at least 60 hours retaining its cholesterol-
reducing ability at the same time.  
The morphology of E. coprostanoligenes was re-affirmed with the aid of confocal 
and transmission electron microscopy. These bacteria were coccobacilloid cells of 0.5 to 
0.7 µm in diameter and 1 to 1.2 µm in length.  
The cholesterol reduction activity in E. coprostanoligenes was further explored so 
as to obtain more knowledge for its future application. A kinetics study of cholesterol 
reduction activity in these bacteria showed a Vmax of 14 µM cholesterol reduced/h and Km 
of 1 mM cholesterol. Secretion of the putative cholesterol reducing enzyme(s) appeared 
to be constitutive and intracellular. Attempts made to isolate these enzyme(s) by lysing 
the bacterial cells were not successful. On the other hand, cholesterol reduction pathway 
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in E. coprostanoligenes was elucidated in the sequence of cholesterol → 5-cholestern-3-
one → 4-cholesten-3-one → coprostan-3-one → coprostanol. Postulation of cholesterol 
oxidase in the bacteria has yet to be confirmed. 
Further investigations could be carried out to confirm the existence of cholesterol 
oxidase in E. coprostanoligenes. Molecular cloning of cholesterol oxidase gene could be 
a possible approach. It would also be useful to isolate and characterize the enzyme(s) 
catalyzing the conversion of 4-cholesten-3-one to coprostanol. Encapsulation of these 
enzymes for hypercholesterolemia treatment could then be made possible if the enzyme(s) 
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